Page 8 of 12

MI3.10-13 | Blood & Tissue Parasites and HIV/AIDS — Glossary

Glossary — MI3.10-13 | Blood & Tissue Parasites and HIV/AIDS

Key terms in this module. Tap a term to see its definition.

4th-generation ELISA

HIV screening assay detecting both p24 antigen and HIV antibodies (IgM/IgG for HIV-1 and HIV-2); window period ~18 days; >99.5% sensitivity

AIDS (Acquired Immunodeficiency Syndrome)

Advanced HIV disease defined by CD4+ <200 cells/μL OR occurrence of an AIDS-defining opportunistic infection or malignancy

Appliqué (accolé) form

Ring form of P. falciparum lying flat against the inner RBC membrane edge — a hallmark of P. falciparum on smear

Artemisinin-based combination therapy (ACT)

First-line treatment for uncomplicated P. falciparum malaria — artemether-lumefantrine or artesunate-amodiaquine; IV artesunate for severe malaria

Blackwater fever

Massive intravascular haemolysis in P. falciparum malaria → haemoglobinuria (dark/black urine) → acute tubular necrosis; rare, associated with quinine use in G6PD-deficient patients

CCR5

Chemokine co-receptor used by macrophage-tropic HIV-1 strains for cell entry; CCR5 delta-32 homozygous mutation confers resistance to HIV; targeted by maraviroc

CD4+ T lymphocyte

T-helper cell; primary target of HIV; normal count 500–1,500 cells/μL; count guides OI prophylaxis and defines AIDS (<200 cells/μL)

Cerebral malaria

Life-threatening complication of P. falciparum — unarousable coma from microvasculature sequestration in the brain; treated with IV artesunate

CrAg (Cryptococcal antigen)

Latex agglutination or lateral flow assay detecting cryptococcal polysaccharide antigen in CSF or serum; near 100% sensitive in active cryptococcal meningitis

Cryptococcus neoformans

Encapsulated yeast causing subacute meningitis at CD4 <100; diagnosed by India ink stain + CrAg test; treated with amphotericin B + flucytosine

CXCR4

Chemokine co-receptor used by T-cell-tropic HIV-1 strains; becomes predominant in late HIV infection

Dolutegravir (DTG)

Integrase strand transfer inhibitor (INSTI); part of India's first-line ART regimen (TDF + 3TC + DTG); high barrier to resistance, once-daily, well-tolerated

Early Infant Diagnosis (EID)

HIV DNA PCR used to detect HIV infection in infants <18 months born to HIV-positive mothers; maternal antibodies make ELISA unreliable until 18 months

Elephantiasis

Gross lymphoedema of lower limbs, scrotum, or breast caused by adult filarial worms blocking lymphatics; irreversible in advanced cases

G6PD deficiency

X-linked enzymatic defect causing haemolysis when exposed to oxidant drugs (primaquine, dapsone) — must be tested before radical cure with primaquine

Gametocyte

Sexual form of Plasmodium in peripheral blood; ingested by Anopheles to continue the sexual (sporogonic) cycle in the mosquito

Gp120

Surface glycoprotein of HIV envelope; binds CD4 receptor and CCR5 or CXCR4 co-receptor to initiate viral entry into target cells

Gp41

Transmembrane HIV glycoprotein; mediates fusion of viral and host cell membranes after gp120-receptor binding

HAART (Highly Active Antiretroviral Therapy)

Combination of ≥3 antiretroviral drugs from ≥2 classes targeting HIV at multiple steps; suppresses viral load to undetectable levels and restores immunity

HIV (Human Immunodeficiency Virus)

Lentivirus (retrovirus) causing AIDS; two types — HIV-1 (pandemic) and HIV-2 (West Africa); targets CD4+ T lymphocytes via gp120-CD4-CCR5/CXCR4 interaction

Hypnozoite

Dormant liver form of P. vivax and P. ovale; reactivates months to years later causing relapse; eliminated only by primaquine

India ink stain

Negative staining technique for CSF examination; encapsulated Cryptococcus neoformans appears as clear halo (capsule) against dark background

Integrase

HIV enzyme that inserts proviral DNA into the host cell chromosome, establishing latent infection; target for integrase inhibitors (e.g., dolutegravir)

IRIS (Immune Reconstitution Inflammatory Syndrome)

Paradoxical clinical worsening of a pre-existing OI after ART initiation due to restoration of pathogen-specific immune responses; occurs 4–8 weeks after ART start

LD body (Leishman-Donovan body)

Amastigote form of Leishmania — oval, 2–4 μm, with nucleus and rod-shaped kinetoplast; found intracellularly in macrophages in tissue smears

Leishmania donovani

Protozoan causing visceral leishmaniasis (kala-azar); amastigotes reside in macrophages of bone marrow, liver, spleen; transmitted by Phlebotomus sandfly

Maurer's clefts

Coarse, irregular stippling in P. falciparum-infected RBCs; less visible than Schüffner's dots; related to knob formation

Merozoite

Asexual progeny released when a schizont-infected RBC ruptures; invades new RBCs to continue the erythrocytic cycle

Microfilaria

Early larval stage of filarial worms found in peripheral blood (or lymphatics); nocturnal periodicity — peak concentration in blood at 10 PM–2 AM

NACO (National AIDS Control Organisation)

Apex body under the Ministry of Health & Family Welfare, India, responsible for the national AIDS control programme, ICTC, ART centres, and NACP

Nocturnal periodicity

Phenomenon where microfilariae of Wuchereria bancrofti accumulate in peripheral blood between 10 PM–2 AM, corresponding to Culex mosquito peak biting activity

Opportunistic infection (OI)

Infection by organisms that rarely cause disease in immunocompetent hosts but exploit immune suppression; CD4 count predicts which OI is likely

PEP (Post-Exposure Prophylaxis)

28-day course of ART (TDF + 3TC + DTG) started within 72 hours of HIV exposure (sexual, occupational, or other); reduces transmission risk by ~80% if taken correctly

PfEMP1

P. falciparum erythrocyte membrane protein 1 — expressed on surface of infected RBCs; mediates cytoadherence to endothelium causing sequestration in cerebral malaria

Phlebotomus sandfly

Vector of Leishmania donovani in India — nocturnal, small (2 mm), breeds in moist sandy soil; bites at floor level; controlled by indoor residual spraying

Plasmodium

Genus of apicomplexan protozoan parasites causing malaria; four species infect humans: P. falciparum, P. vivax, P. ovale, P. malariae

PMTCT

Prevention of Mother-to-Child Transmission — universal antenatal HIV testing, ART for HIV-positive pregnant women, infant NVP prophylaxis, EID testing; reduces MTCT from 25–45% to <2%

Pneumocystis jirovecii

Fungus (formerly classified as protozoan) causing PCP — the commonest AIDS-defining OI in non-India settings; interstitial pneumonia at CD4 <200; diagnosed by GMS stain of BAL

PrEP (Pre-Exposure Prophylaxis)

Daily TDF-emtricitabine taken by HIV-negative high-risk individuals to prevent acquisition of HIV; >90% effective with adherence

Proviral DNA

HIV genome integrated into the host chromosome by integrase; persists for the life of the cell — the latent reservoir not eliminated by current ART

Recrudescence

Recurrence of P. falciparum or P. malariae malaria from persistent low-level erythrocytic parasitaemia — not from liver forms; due to incomplete treatment

Relapse (malaria)

Recurrence of P. vivax or P. ovale malaria from hypnozoite reactivation — can occur months to years after primary infection; prevented by primaquine

Reverse transcriptase

HIV enzyme that converts the RNA genome into double-stranded DNA (proviral DNA); error-prone — generates mutations that drive drug resistance

RK39 test

Rapid immunochromatographic strip test detecting anti-rK39 IgG antibodies in kala-azar; >95% sensitive/specific in the Indian subcontinent; field-applicable

Schizogony

Asexual multiplication by multiple fission — nucleus divides repeatedly before cytoplasm divides, producing multiple progeny (merozoites or schizonts)

Schüffner's dots

Fine eosinophilic stippling of infected RBCs seen in P. vivax and P. ovale; represents parasite-modified RBC membrane caveolae

Sporozoite

Infective form of Plasmodium injected by Anopheles mosquito; travels to liver to initiate exo-erythrocytic schizogony

U=U (Undetectable = Untransmittable)

Scientific consensus that a person living with HIV on effective ART with undetectable viral load (<200 copies/mL) cannot sexually transmit HIV

Window period

Interval between HIV infection and detectable antibodies/antigen on laboratory tests; 18 days for 4th-generation ELISA, 10–12 days for NAT/PCR

Wuchereria bancrofti

Filarial nematode causing lymphatic filariasis; microfilariae are sheathed with no nuclei in tail tip; transmitted by Culex quinquefasciatus mosquito

50 terms in this module